Plant ID: NPO17295
Plant Latin Name: Chrysanthemum zawadskii
Taxonomy Genus: Chrysanthemum
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
147003
Plant-of-the-World-Online:
n.a.
South Korea
TSHR; | |
TRPA1; | |
MAPK1; | |
PPARA; PPARD; | |
TLR2; | |
TP53; | |
MAPT; FABP3; LMNA; FABP2; FABP4; FABP5; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 2.949E-09 | 2.141E-05 | FABP2, FABP3, FABP4, FABP5 |
MF | GO:0005488; binding | GO:0019902; phosphatase binding | 6.357E-06 | 5.537E-03 | MAPK1, MAPT, PPARA, TP53 |
MF | GO:0005488; binding | GO:0097371; MDM2/MDM4 family protein binding | 1.179E-05 | 9.172E-03 | PPARA, TP53 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 1.762E-05 | 1.279E-02 | FABP3, PPARA, PPARD |
BP | GO:0051179; localization | GO:0006810; transport | 2.142E-05 | 1.434E-02 | FABP3, FABP5, LMNA, MAPK1, MAPT, PPARA, PPARD, SMN1, SMN2, TLR2, TRPA1 |
BP | GO:0032502; developmental process | GO:0048856; anatomical structure development | 2.174E-05 | 1.434E-02 | FABP5, LMNA, MAPK1, PPARA, PPARD, SMN1, SMN2, TLR2, TP53, TSHR |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 3.083E-05 | 1.815E-02 | FABP3, PPARD |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 3.698E-05 | 2.119E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 4.369E-05 | 2.378E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 8.550E-05 | 3.724E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 8.878E-05 | 3.791E-02 | MAPK1, SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 6.592E-12 | 7.911E-10 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.436E-04 | 4.878E-03 | LMNA, MAPK1, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 1.234E-04 | 4.878E-03 | MAPK1, PPARA, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 1.626E-04 | 4.878E-03 | MAPK1, TP53, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 4.284E-04 | 6.427E-03 | MAPK1, TP53, TLR2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 4.042E-04 | 6.427E-03 | MAPK1, PPARA, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 2.107E-04 | 5.056E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 4.233E-04 | 6.427E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 6.813E-04 | 7.681E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 7.898E-04 | 7.681E-03 | MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 8.321E-04 | 7.681E-03 | MAPK1, MAPT, TP53 |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 7.898E-04 | 7.681E-03 | FABP4, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 8.182E-04 | 7.681E-03 | MAPK1, PPARD |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 1.063E-03 | 7.967E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 9.673E-04 | 7.967E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.095E-03 | 7.967E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 1.266E-03 | 8.028E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.129E-03 | 7.967E-03 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.338E-03 | 8.028E-03 | MAPK1, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 1.338E-03 | 8.028E-03 | MAPK1, TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; TP53; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |